nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—PTGS2—muscle cancer	0.433	1	CbGaD
Ketoprofen—SLC22A11—Methotrexate—muscle cancer	0.0642	0.147	CbGbCtD
Ketoprofen—SLC22A7—Methotrexate—muscle cancer	0.0612	0.14	CbGbCtD
Ketoprofen—ABCC4—Methotrexate—muscle cancer	0.0598	0.137	CbGbCtD
Ketoprofen—PTGS2—Etoposide—muscle cancer	0.0532	0.122	CbGbCtD
Ketoprofen—PTGS1—Etoposide—muscle cancer	0.0449	0.103	CbGbCtD
Ketoprofen—SLCO1A2—Methotrexate—muscle cancer	0.0429	0.098	CbGbCtD
Ketoprofen—SLC22A8—Methotrexate—muscle cancer	0.0373	0.0854	CbGbCtD
Ketoprofen—SLC22A6—Methotrexate—muscle cancer	0.026	0.0595	CbGbCtD
Ketoprofen—CYP2C8—Etoposide—muscle cancer	0.0259	0.0592	CbGbCtD
Ketoprofen—ALB—Methotrexate—muscle cancer	0.0221	0.0506	CbGbCtD
Ketoprofen—CXCR1—bone marrow—muscle cancer	0.0025	0.119	CbGeAlD
Ketoprofen—PTGS2—hindlimb—muscle cancer	0.00144	0.0689	CbGeAlD
Ketoprofen—PTGS2—appendage—muscle cancer	0.00124	0.0591	CbGeAlD
Ketoprofen—CXCL8—smooth muscle tissue—muscle cancer	0.00122	0.0582	CbGeAlD
Ketoprofen—SLC22A11—renal system—muscle cancer	0.000971	0.0464	CbGeAlD
Ketoprofen—SLC22A7—renal system—muscle cancer	0.000948	0.0453	CbGeAlD
Ketoprofen—CXCL8—bone marrow—muscle cancer	0.000886	0.0423	CbGeAlD
Ketoprofen—CXCL8—vagina—muscle cancer	0.000849	0.0406	CbGeAlD
Ketoprofen—CXCL8—testis—muscle cancer	0.000758	0.0362	CbGeAlD
Ketoprofen—Carprofen—PTGS2—muscle cancer	0.000665	0.109	CrCbGaD
Ketoprofen—Ketorolac—PTGS2—muscle cancer	0.000665	0.109	CrCbGaD
Ketoprofen—Bromfenac—PTGS2—muscle cancer	0.000638	0.105	CrCbGaD
Ketoprofen—SLC22A7—testis—muscle cancer	0.000613	0.0293	CbGeAlD
Ketoprofen—SLCO1A2—renal system—muscle cancer	0.000574	0.0274	CbGeAlD
Ketoprofen—ABCC4—renal system—muscle cancer	0.000552	0.0264	CbGeAlD
Ketoprofen—SLC22A8—renal system—muscle cancer	0.000548	0.0262	CbGeAlD
Ketoprofen—Tiaprofenic acid—PTGS2—muscle cancer	0.000542	0.0889	CrCbGaD
Ketoprofen—Nepafenac—PTGS2—muscle cancer	0.000516	0.0846	CrCbGaD
Ketoprofen—Magnesium salicylate—PTGS2—muscle cancer	0.000504	0.0826	CrCbGaD
Ketoprofen—Fenbufen—PTGS2—muscle cancer	0.000493	0.0809	CrCbGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MYF5—muscle cancer	0.000478	0.066	CbGpPWpGaD
Ketoprofen—ABCC4—tendon—muscle cancer	0.000431	0.0206	CbGeAlD
Ketoprofen—Salsalate—PTGS2—muscle cancer	0.000429	0.0703	CrCbGaD
Ketoprofen—ABCC4—bone marrow—muscle cancer	0.000418	0.02	CbGeAlD
Ketoprofen—Suprofen—PTGS2—muscle cancer	0.000411	0.0674	CrCbGaD
Ketoprofen—PTGS2—embryo—muscle cancer	0.000411	0.0196	CbGeAlD
Ketoprofen—CYP2C8—renal system—muscle cancer	0.000401	0.0192	CbGeAlD
Ketoprofen—SLCO1A2—head—muscle cancer	0.000384	0.0183	CbGeAlD
Ketoprofen—SLCO1A2—testis—muscle cancer	0.000371	0.0177	CbGeAlD
Ketoprofen—ABCC4—head—muscle cancer	0.00037	0.0177	CbGeAlD
Ketoprofen—ALB—testis—muscle cancer	0.000369	0.0176	CbGeAlD
Ketoprofen—SLC22A8—head—muscle cancer	0.000367	0.0175	CbGeAlD
Ketoprofen—ABCC4—testis—muscle cancer	0.000357	0.0171	CbGeAlD
Ketoprofen—Fenoprofen—PTGS2—muscle cancer	0.000354	0.0581	CrCbGaD
Ketoprofen—PTGS1—smooth muscle tissue—muscle cancer	0.000338	0.0161	CbGeAlD
Ketoprofen—Discomfort—Dactinomycin—muscle cancer	0.000337	0.00354	CcSEcCtD
Ketoprofen—Melaena—Doxorubicin—muscle cancer	0.000336	0.00353	CcSEcCtD
Ketoprofen—Salivary hypersecretion—Doxorubicin—muscle cancer	0.000334	0.00351	CcSEcCtD
Ketoprofen—Diabetes mellitus—Methotrexate—muscle cancer	0.000332	0.00349	CcSEcCtD
Ketoprofen—Anaemia—Vincristine—muscle cancer	0.000331	0.00348	CcSEcCtD
Ketoprofen—Colitis—Doxorubicin—muscle cancer	0.00033	0.00347	CcSEcCtD
Ketoprofen—Photosensitivity—Methotrexate—muscle cancer	0.000329	0.00345	CcSEcCtD
Ketoprofen—Mefenamic acid—PTGS2—muscle cancer	0.000329	0.0539	CrCbGaD
Ketoprofen—Oedema—Dactinomycin—muscle cancer	0.000327	0.00344	CcSEcCtD
Ketoprofen—PTGS1—renal system—muscle cancer	0.000325	0.0155	CbGeAlD
Ketoprofen—Infection—Dactinomycin—muscle cancer	0.000325	0.00342	CcSEcCtD
Ketoprofen—Blood urea increased—Doxorubicin—muscle cancer	0.000325	0.00342	CcSEcCtD
Ketoprofen—Aplastic anaemia—Doxorubicin—muscle cancer	0.000323	0.0034	CcSEcCtD
Ketoprofen—PTGS2—smooth muscle tissue—muscle cancer	0.000323	0.0154	CbGeAlD
Ketoprofen—Naproxen—PTGS2—muscle cancer	0.000322	0.0529	CrCbGaD
Ketoprofen—Vertigo—Vincristine—muscle cancer	0.000322	0.00338	CcSEcCtD
Ketoprofen—Thrombocytopenia—Dactinomycin—muscle cancer	0.00032	0.00337	CcSEcCtD
Ketoprofen—Erythema multiforme—Etoposide—muscle cancer	0.000315	0.00331	CcSEcCtD
Ketoprofen—Anorexia—Dactinomycin—muscle cancer	0.000312	0.00328	CcSEcCtD
Ketoprofen—Mouth ulceration—Doxorubicin—muscle cancer	0.000311	0.00327	CcSEcCtD
Ketoprofen—PTGS2—renal system—muscle cancer	0.000311	0.0148	CbGeAlD
Ketoprofen—Convulsion—Vincristine—muscle cancer	0.00031	0.00326	CcSEcCtD
Ketoprofen—Flushing—Etoposide—muscle cancer	0.000309	0.00325	CcSEcCtD
Ketoprofen—Hypertension—Vincristine—muscle cancer	0.000309	0.00325	CcSEcCtD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MYOG—muscle cancer	0.000308	0.0425	CbGpPWpGaD
Ketoprofen—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000306	0.00321	CcSEcCtD
Ketoprofen—Myalgia—Vincristine—muscle cancer	0.000305	0.0032	CcSEcCtD
Ketoprofen—Visual disturbance—Methotrexate—muscle cancer	0.000304	0.0032	CcSEcCtD
Ketoprofen—Chills—Etoposide—muscle cancer	0.000299	0.00314	CcSEcCtD
Ketoprofen—Sepsis—Doxorubicin—muscle cancer	0.000299	0.00314	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000298	0.00313	CcSEcCtD
Ketoprofen—Alopecia—Etoposide—muscle cancer	0.000294	0.0031	CcSEcCtD
Ketoprofen—Anaphylactic shock—Vincristine—muscle cancer	0.000292	0.00307	CcSEcCtD
Ketoprofen—Oedema—Vincristine—muscle cancer	0.000292	0.00307	CcSEcCtD
Ketoprofen—PTGS1—cardiac atrium—muscle cancer	0.000291	0.0139	CbGeAlD
Ketoprofen—CYP2C8—vagina—muscle cancer	0.00029	0.0139	CbGeAlD
Ketoprofen—Infection—Vincristine—muscle cancer	0.00029	0.00305	CcSEcCtD
Ketoprofen—Diabetes mellitus—Doxorubicin—muscle cancer	0.000287	0.00302	CcSEcCtD
Ketoprofen—Thrombocytopenia—Vincristine—muscle cancer	0.000286	0.00301	CcSEcCtD
Ketoprofen—Hepatic function abnormal—Doxorubicin—muscle cancer	0.000286	0.003	CcSEcCtD
Ketoprofen—Photosensitivity—Doxorubicin—muscle cancer	0.000284	0.00299	CcSEcCtD
Ketoprofen—Decreased appetite—Dactinomycin—muscle cancer	0.000284	0.00299	CcSEcCtD
Ketoprofen—Dysgeusia—Etoposide—muscle cancer	0.000284	0.00299	CcSEcCtD
Ketoprofen—Hyperhidrosis—Vincristine—muscle cancer	0.000283	0.00297	CcSEcCtD
Ketoprofen—Fatigue—Dactinomycin—muscle cancer	0.000282	0.00296	CcSEcCtD
Ketoprofen—Vascular purpura—Doxorubicin—muscle cancer	0.000279	0.00294	CcSEcCtD
Ketoprofen—Anorexia—Vincristine—muscle cancer	0.000279	0.00293	CcSEcCtD
Ketoprofen—Eczema—Doxorubicin—muscle cancer	0.000278	0.00292	CcSEcCtD
Ketoprofen—Eye pain—Doxorubicin—muscle cancer	0.000277	0.00291	CcSEcCtD
Ketoprofen—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000275	0.0029	CcSEcCtD
Ketoprofen—Feeling abnormal—Dactinomycin—muscle cancer	0.00027	0.00283	CcSEcCtD
Ketoprofen—Ill-defined disorder—Etoposide—muscle cancer	0.000269	0.00283	CcSEcCtD
Ketoprofen—Anaemia—Etoposide—muscle cancer	0.000268	0.00282	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000267	0.00281	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000266	0.0028	CcSEcCtD
Ketoprofen—Increased appetite—Doxorubicin—muscle cancer	0.000266	0.0028	CcSEcCtD
Ketoprofen—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000265	0.00278	CcSEcCtD
Ketoprofen—Insomnia—Vincristine—muscle cancer	0.000264	0.00278	CcSEcCtD
Ketoprofen—Renal impairment—Doxorubicin—muscle cancer	0.000262	0.00276	CcSEcCtD
Ketoprofen—Paraesthesia—Vincristine—muscle cancer	0.000262	0.00276	CcSEcCtD
Ketoprofen—Malaise—Etoposide—muscle cancer	0.000262	0.00275	CcSEcCtD
Ketoprofen—Dermatitis bullous—Doxorubicin—muscle cancer	0.000261	0.00275	CcSEcCtD
Ketoprofen—Vertigo—Etoposide—muscle cancer	0.000261	0.00274	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00026	0.00273	CcSEcCtD
Ketoprofen—Purpura—Doxorubicin—muscle cancer	0.000259	0.00272	CcSEcCtD
Ketoprofen—CYP2C8—testis—muscle cancer	0.000259	0.0124	CbGeAlD
Ketoprofen—Abdominal pain—Dactinomycin—muscle cancer	0.000259	0.00272	CcSEcCtD
Ketoprofen—Cardiac failure—Doxorubicin—muscle cancer	0.000256	0.00269	CcSEcCtD
Ketoprofen—Decreased appetite—Vincristine—muscle cancer	0.000254	0.00267	CcSEcCtD
Ketoprofen—PTGS1—tendon—muscle cancer	0.000254	0.0121	CbGeAlD
Ketoprofen—CXCR1—GPCRs, Other—CNR1—muscle cancer	0.000254	0.035	CbGpPWpGaD
Ketoprofen—Gastrointestinal disorder—Vincristine—muscle cancer	0.000252	0.00265	CcSEcCtD
Ketoprofen—Fatigue—Vincristine—muscle cancer	0.000252	0.00265	CcSEcCtD
Ketoprofen—Convulsion—Etoposide—muscle cancer	0.000251	0.00264	CcSEcCtD
Ketoprofen—Hyponatraemia—Doxorubicin—muscle cancer	0.000251	0.00264	CcSEcCtD
Ketoprofen—Hypertension—Etoposide—muscle cancer	0.00025	0.00263	CcSEcCtD
Ketoprofen—Constipation—Vincristine—muscle cancer	0.00025	0.00263	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00025	0.00263	CcSEcCtD
Ketoprofen—Asthma—Methotrexate—muscle cancer	0.000249	0.00262	CcSEcCtD
Ketoprofen—Migraine—Doxorubicin—muscle cancer	0.000246	0.00258	CcSEcCtD
Ketoprofen—Pancreatitis—Methotrexate—muscle cancer	0.000244	0.00257	CcSEcCtD
Ketoprofen—Discomfort—Etoposide—muscle cancer	0.000244	0.00256	CcSEcCtD
Ketoprofen—PTGS2—tendon—muscle cancer	0.000243	0.0116	CbGeAlD
Ketoprofen—CXCR1—Differentiation Pathway—KIT—muscle cancer	0.000242	0.0335	CbGpPWpGaD
Ketoprofen—Face oedema—Doxorubicin—muscle cancer	0.000241	0.00254	CcSEcCtD
Ketoprofen—Hypersensitivity—Dactinomycin—muscle cancer	0.000241	0.00253	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Vincristine—muscle cancer	0.000239	0.00251	CcSEcCtD
Ketoprofen—Confusional state—Etoposide—muscle cancer	0.000239	0.00251	CcSEcCtD
Ketoprofen—Anaphylactic shock—Etoposide—muscle cancer	0.000237	0.00249	CcSEcCtD
Ketoprofen—PTGS1—vagina—muscle cancer	0.000236	0.0113	CbGeAlD
Ketoprofen—Infection—Etoposide—muscle cancer	0.000235	0.00247	CcSEcCtD
Ketoprofen—PTGS2—bone marrow—muscle cancer	0.000235	0.0112	CbGeAlD
Ketoprofen—Asthenia—Dactinomycin—muscle cancer	0.000235	0.00247	CcSEcCtD
Ketoprofen—Thrombocytopenia—Etoposide—muscle cancer	0.000232	0.00244	CcSEcCtD
Ketoprofen—Flurbiprofen—PTGS2—muscle cancer	0.000231	0.0379	CrCbGaD
Ketoprofen—Tachycardia—Etoposide—muscle cancer	0.000231	0.00243	CcSEcCtD
Ketoprofen—Abdominal pain—Vincristine—muscle cancer	0.000231	0.00243	CcSEcCtD
Ketoprofen—Erectile dysfunction—Methotrexate—muscle cancer	0.00023	0.00241	CcSEcCtD
Ketoprofen—Hyperhidrosis—Etoposide—muscle cancer	0.000229	0.00241	CcSEcCtD
Ketoprofen—Abdominal pain upper—Doxorubicin—muscle cancer	0.000228	0.0024	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Methotrexate—muscle cancer	0.000228	0.00239	CcSEcCtD
Ketoprofen—Anorexia—Etoposide—muscle cancer	0.000226	0.00237	CcSEcCtD
Ketoprofen—PTGS2—vagina—muscle cancer	0.000225	0.0108	CbGeAlD
Ketoprofen—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000225	0.00236	CcSEcCtD
Ketoprofen—Diarrhoea—Dactinomycin—muscle cancer	0.000224	0.00235	CcSEcCtD
Ketoprofen—Drowsiness—Methotrexate—muscle cancer	0.000222	0.00234	CcSEcCtD
Ketoprofen—Gastritis—Doxorubicin—muscle cancer	0.000221	0.00232	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00022	0.00232	CcSEcCtD
Ketoprofen—Renal failure—Methotrexate—muscle cancer	0.000219	0.0023	CcSEcCtD
Ketoprofen—PTGS1—head—muscle cancer	0.000218	0.0104	CbGeAlD
Ketoprofen—Stomatitis—Methotrexate—muscle cancer	0.000217	0.00228	CcSEcCtD
Ketoprofen—Conjunctivitis—Methotrexate—muscle cancer	0.000216	0.00227	CcSEcCtD
Ketoprofen—Asthma—Doxorubicin—muscle cancer	0.000216	0.00227	CcSEcCtD
Ketoprofen—Hypersensitivity—Vincristine—muscle cancer	0.000215	0.00226	CcSEcCtD
Ketoprofen—Sweating—Methotrexate—muscle cancer	0.000213	0.00224	CcSEcCtD
Ketoprofen—Paraesthesia—Etoposide—muscle cancer	0.000213	0.00223	CcSEcCtD
Ketoprofen—Haematuria—Methotrexate—muscle cancer	0.000212	0.00223	CcSEcCtD
Ketoprofen—Pancreatitis—Doxorubicin—muscle cancer	0.000212	0.00223	CcSEcCtD
Ketoprofen—Dyspnoea—Etoposide—muscle cancer	0.000211	0.00222	CcSEcCtD
Ketoprofen—Somnolence—Etoposide—muscle cancer	0.00021	0.00221	CcSEcCtD
Ketoprofen—PTGS1—testis—muscle cancer	0.00021	0.01	CbGeAlD
Ketoprofen—Epistaxis—Methotrexate—muscle cancer	0.00021	0.0022	CcSEcCtD
Ketoprofen—Asthenia—Vincristine—muscle cancer	0.00021	0.0022	CcSEcCtD
Ketoprofen—Vomiting—Dactinomycin—muscle cancer	0.000208	0.00219	CcSEcCtD
Ketoprofen—PTGS2—head—muscle cancer	0.000208	0.00993	CbGeAlD
Ketoprofen—Agranulocytosis—Methotrexate—muscle cancer	0.000207	0.00218	CcSEcCtD
Ketoprofen—Rash—Dactinomycin—muscle cancer	0.000206	0.00217	CcSEcCtD
Ketoprofen—Decreased appetite—Etoposide—muscle cancer	0.000206	0.00216	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Etoposide—muscle cancer	0.000204	0.00215	CcSEcCtD
Ketoprofen—Fatigue—Etoposide—muscle cancer	0.000204	0.00215	CcSEcCtD
Ketoprofen—Constipation—Etoposide—muscle cancer	0.000202	0.00213	CcSEcCtD
Ketoprofen—PTGS2—C-MYB transcription factor network—MYF6—muscle cancer	0.000201	0.0278	CbGpPWpGaD
Ketoprofen—Diarrhoea—Vincristine—muscle cancer	0.0002	0.0021	CcSEcCtD
Ketoprofen—Hepatitis—Methotrexate—muscle cancer	0.0002	0.0021	CcSEcCtD
Ketoprofen—Pharyngitis—Methotrexate—muscle cancer	0.000198	0.00208	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000197	0.00207	CcSEcCtD
Ketoprofen—Weight increased—Doxorubicin—muscle cancer	0.000196	0.00207	CcSEcCtD
Ketoprofen—Weight decreased—Doxorubicin—muscle cancer	0.000195	0.00205	CcSEcCtD
Ketoprofen—Feeling abnormal—Etoposide—muscle cancer	0.000195	0.00205	CcSEcCtD
Ketoprofen—Nausea—Dactinomycin—muscle cancer	0.000194	0.00204	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Etoposide—muscle cancer	0.000194	0.00203	CcSEcCtD
Ketoprofen—Dizziness—Vincristine—muscle cancer	0.000193	0.00203	CcSEcCtD
Ketoprofen—Drowsiness—Doxorubicin—muscle cancer	0.000193	0.00202	CcSEcCtD
Ketoprofen—Visual impairment—Methotrexate—muscle cancer	0.000192	0.00202	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000191	0.00201	CcSEcCtD
Ketoprofen—Renal failure—Doxorubicin—muscle cancer	0.000189	0.00199	CcSEcCtD
Ketoprofen—Erythema multiforme—Methotrexate—muscle cancer	0.000189	0.00198	CcSEcCtD
Ketoprofen—Urticaria—Etoposide—muscle cancer	0.000188	0.00198	CcSEcCtD
Ketoprofen—Jaundice—Doxorubicin—muscle cancer	0.000188	0.00197	CcSEcCtD
Ketoprofen—Stomatitis—Doxorubicin—muscle cancer	0.000188	0.00197	CcSEcCtD
Ketoprofen—Abdominal pain—Etoposide—muscle cancer	0.000187	0.00197	CcSEcCtD
Ketoprofen—Conjunctivitis—Doxorubicin—muscle cancer	0.000187	0.00197	CcSEcCtD
Ketoprofen—Tinnitus—Methotrexate—muscle cancer	0.000186	0.00196	CcSEcCtD
Ketoprofen—Vomiting—Vincristine—muscle cancer	0.000186	0.00195	CcSEcCtD
Ketoprofen—Sweating—Doxorubicin—muscle cancer	0.000185	0.00194	CcSEcCtD
Ketoprofen—Rash—Vincristine—muscle cancer	0.000184	0.00194	CcSEcCtD
Ketoprofen—Dermatitis—Vincristine—muscle cancer	0.000184	0.00194	CcSEcCtD
Ketoprofen—Haematuria—Doxorubicin—muscle cancer	0.000184	0.00193	CcSEcCtD
Ketoprofen—Headache—Vincristine—muscle cancer	0.000183	0.00192	CcSEcCtD
Ketoprofen—Epistaxis—Doxorubicin—muscle cancer	0.000182	0.00191	CcSEcCtD
Ketoprofen—Agranulocytosis—Doxorubicin—muscle cancer	0.00018	0.00189	CcSEcCtD
Ketoprofen—Chills—Methotrexate—muscle cancer	0.000179	0.00188	CcSEcCtD
Ketoprofen—Alopecia—Methotrexate—muscle cancer	0.000176	0.00185	CcSEcCtD
Ketoprofen—ABCC4—Ectoderm Differentiation—PAX3—muscle cancer	0.000175	0.0242	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Etoposide—muscle cancer	0.000174	0.00183	CcSEcCtD
Ketoprofen—CXCL8—Overview of nanoparticle effects—PTGS2—muscle cancer	0.000174	0.0241	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—muscle cancer	0.000174	0.024	CbGpPWpGaD
Ketoprofen—Erythema—Methotrexate—muscle cancer	0.000174	0.00183	CcSEcCtD
Ketoprofen—Nausea—Vincristine—muscle cancer	0.000174	0.00182	CcSEcCtD
Ketoprofen—Rhinitis—Doxorubicin—muscle cancer	0.000173	0.00182	CcSEcCtD
Ketoprofen—Hepatitis—Doxorubicin—muscle cancer	0.000173	0.00182	CcSEcCtD
Ketoprofen—Pharyngitis—Doxorubicin—muscle cancer	0.000172	0.0018	CcSEcCtD
Ketoprofen—Dysgeusia—Methotrexate—muscle cancer	0.00017	0.00179	CcSEcCtD
Ketoprofen—Asthenia—Etoposide—muscle cancer	0.00017	0.00179	CcSEcCtD
Ketoprofen—Pruritus—Etoposide—muscle cancer	0.000167	0.00176	CcSEcCtD
Ketoprofen—Visual impairment—Doxorubicin—muscle cancer	0.000167	0.00175	CcSEcCtD
Ketoprofen—Erythema multiforme—Doxorubicin—muscle cancer	0.000163	0.00172	CcSEcCtD
Ketoprofen—Diarrhoea—Etoposide—muscle cancer	0.000162	0.0017	CcSEcCtD
Ketoprofen—Ill-defined disorder—Methotrexate—muscle cancer	0.000161	0.00169	CcSEcCtD
Ketoprofen—Tinnitus—Doxorubicin—muscle cancer	0.000161	0.00169	CcSEcCtD
Ketoprofen—Anaemia—Methotrexate—muscle cancer	0.000161	0.00169	CcSEcCtD
Ketoprofen—Flushing—Doxorubicin—muscle cancer	0.00016	0.00169	CcSEcCtD
Ketoprofen—Malaise—Methotrexate—muscle cancer	0.000157	0.00165	CcSEcCtD
Ketoprofen—Dizziness—Etoposide—muscle cancer	0.000157	0.00165	CcSEcCtD
Ketoprofen—Vertigo—Methotrexate—muscle cancer	0.000156	0.00164	CcSEcCtD
Ketoprofen—Chills—Doxorubicin—muscle cancer	0.000155	0.00163	CcSEcCtD
Ketoprofen—Arrhythmia—Doxorubicin—muscle cancer	0.000154	0.00162	CcSEcCtD
Ketoprofen—Alopecia—Doxorubicin—muscle cancer	0.000153	0.00161	CcSEcCtD
Ketoprofen—Convulsion—Methotrexate—muscle cancer	0.000151	0.00158	CcSEcCtD
Ketoprofen—Vomiting—Etoposide—muscle cancer	0.000151	0.00158	CcSEcCtD
Ketoprofen—Erythema—Doxorubicin—muscle cancer	0.00015	0.00158	CcSEcCtD
Ketoprofen—Rash—Etoposide—muscle cancer	0.000149	0.00157	CcSEcCtD
Ketoprofen—Dermatitis—Etoposide—muscle cancer	0.000149	0.00157	CcSEcCtD
Ketoprofen—Headache—Etoposide—muscle cancer	0.000148	0.00156	CcSEcCtD
Ketoprofen—Flatulence—Doxorubicin—muscle cancer	0.000148	0.00156	CcSEcCtD
Ketoprofen—Myalgia—Methotrexate—muscle cancer	0.000148	0.00155	CcSEcCtD
Ketoprofen—Tension—Doxorubicin—muscle cancer	0.000148	0.00155	CcSEcCtD
Ketoprofen—Dysgeusia—Doxorubicin—muscle cancer	0.000147	0.00155	CcSEcCtD
Ketoprofen—Discomfort—Methotrexate—muscle cancer	0.000146	0.00154	CcSEcCtD
Ketoprofen—Nervousness—Doxorubicin—muscle cancer	0.000146	0.00154	CcSEcCtD
Ketoprofen—CXCR1—Differentiation Pathway—VEGFA—muscle cancer	0.000145	0.02	CbGpPWpGaD
Ketoprofen—Confusional state—Methotrexate—muscle cancer	0.000143	0.0015	CcSEcCtD
Ketoprofen—Anaphylactic shock—Methotrexate—muscle cancer	0.000142	0.00149	CcSEcCtD
Ketoprofen—Infection—Methotrexate—muscle cancer	0.000141	0.00148	CcSEcCtD
Ketoprofen—Nausea—Etoposide—muscle cancer	0.000141	0.00148	CcSEcCtD
Ketoprofen—Ill-defined disorder—Doxorubicin—muscle cancer	0.00014	0.00147	CcSEcCtD
Ketoprofen—Anaemia—Doxorubicin—muscle cancer	0.000139	0.00146	CcSEcCtD
Ketoprofen—Thrombocytopenia—Methotrexate—muscle cancer	0.000139	0.00146	CcSEcCtD
Ketoprofen—Hyperhidrosis—Methotrexate—muscle cancer	0.000137	0.00144	CcSEcCtD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—TP73—muscle cancer	0.000137	0.0189	CbGpPWpGaD
Ketoprofen—Malaise—Doxorubicin—muscle cancer	0.000136	0.00143	CcSEcCtD
Ketoprofen—Vertigo—Doxorubicin—muscle cancer	0.000135	0.00142	CcSEcCtD
Ketoprofen—Anorexia—Methotrexate—muscle cancer	0.000135	0.00142	CcSEcCtD
Ketoprofen—Palpitations—Doxorubicin—muscle cancer	0.000133	0.0014	CcSEcCtD
Ketoprofen—Convulsion—Doxorubicin—muscle cancer	0.00013	0.00137	CcSEcCtD
Ketoprofen—Hypertension—Doxorubicin—muscle cancer	0.00013	0.00137	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000129	0.00136	CcSEcCtD
Ketoprofen—Insomnia—Methotrexate—muscle cancer	0.000128	0.00135	CcSEcCtD
Ketoprofen—Myalgia—Doxorubicin—muscle cancer	0.000128	0.00135	CcSEcCtD
Ketoprofen—Anxiety—Doxorubicin—muscle cancer	0.000128	0.00134	CcSEcCtD
Ketoprofen—Paraesthesia—Methotrexate—muscle cancer	0.000127	0.00134	CcSEcCtD
Ketoprofen—Discomfort—Doxorubicin—muscle cancer	0.000127	0.00133	CcSEcCtD
Ketoprofen—Dyspnoea—Methotrexate—muscle cancer	0.000126	0.00133	CcSEcCtD
Ketoprofen—CXCL8—Bladder Cancer—CDKN2A—muscle cancer	0.000126	0.0174	CbGpPWpGaD
Ketoprofen—Somnolence—Methotrexate—muscle cancer	0.000126	0.00133	CcSEcCtD
Ketoprofen—Dry mouth—Doxorubicin—muscle cancer	0.000125	0.00132	CcSEcCtD
Ketoprofen—Dyspepsia—Methotrexate—muscle cancer	0.000125	0.00131	CcSEcCtD
Ketoprofen—Confusional state—Doxorubicin—muscle cancer	0.000124	0.0013	CcSEcCtD
Ketoprofen—Decreased appetite—Methotrexate—muscle cancer	0.000123	0.0013	CcSEcCtD
Ketoprofen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—muscle cancer	0.000123	0.017	CbGpPWpGaD
Ketoprofen—Anaphylactic shock—Doxorubicin—muscle cancer	0.000123	0.00129	CcSEcCtD
Ketoprofen—Oedema—Doxorubicin—muscle cancer	0.000123	0.00129	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000122	0.00129	CcSEcCtD
Ketoprofen—CXCL8—Bladder Cancer—MDM2—muscle cancer	0.000122	0.0169	CbGpPWpGaD
Ketoprofen—Fatigue—Methotrexate—muscle cancer	0.000122	0.00129	CcSEcCtD
Ketoprofen—Infection—Doxorubicin—muscle cancer	0.000122	0.00128	CcSEcCtD
Ketoprofen—Shock—Doxorubicin—muscle cancer	0.000121	0.00127	CcSEcCtD
Ketoprofen—Thrombocytopenia—Doxorubicin—muscle cancer	0.00012	0.00126	CcSEcCtD
Ketoprofen—Tachycardia—Doxorubicin—muscle cancer	0.00012	0.00126	CcSEcCtD
Ketoprofen—Hyperhidrosis—Doxorubicin—muscle cancer	0.000119	0.00125	CcSEcCtD
Ketoprofen—CXCR1—G alpha (i) signalling events—CNR1—muscle cancer	0.000119	0.0164	CbGpPWpGaD
Ketoprofen—Anorexia—Doxorubicin—muscle cancer	0.000117	0.00123	CcSEcCtD
Ketoprofen—Feeling abnormal—Methotrexate—muscle cancer	0.000117	0.00123	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Methotrexate—muscle cancer	0.000116	0.00122	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—HMGA1—muscle cancer	0.000116	0.016	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—TIMM10—muscle cancer	0.000113	0.0157	CbGpPWpGaD
Ketoprofen—Urticaria—Methotrexate—muscle cancer	0.000113	0.00118	CcSEcCtD
Ketoprofen—Abdominal pain—Methotrexate—muscle cancer	0.000112	0.00118	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000112	0.00118	CcSEcCtD
Ketoprofen—Insomnia—Doxorubicin—muscle cancer	0.000111	0.00117	CcSEcCtD
Ketoprofen—ABCC4—Ectoderm Differentiation—DMD—muscle cancer	0.000111	0.0153	CbGpPWpGaD
Ketoprofen—Paraesthesia—Doxorubicin—muscle cancer	0.00011	0.00116	CcSEcCtD
Ketoprofen—CXCR1—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.00011	0.0152	CbGpPWpGaD
Ketoprofen—Dyspnoea—Doxorubicin—muscle cancer	0.000109	0.00115	CcSEcCtD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—muscle cancer	0.000109	0.0151	CbGpPWpGaD
Ketoprofen—Somnolence—Doxorubicin—muscle cancer	0.000109	0.00115	CcSEcCtD
Ketoprofen—Dyspepsia—Doxorubicin—muscle cancer	0.000108	0.00114	CcSEcCtD
Ketoprofen—Decreased appetite—Doxorubicin—muscle cancer	0.000107	0.00112	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000106	0.00111	CcSEcCtD
Ketoprofen—Fatigue—Doxorubicin—muscle cancer	0.000106	0.00111	CcSEcCtD
Ketoprofen—Constipation—Doxorubicin—muscle cancer	0.000105	0.0011	CcSEcCtD
Ketoprofen—Hypersensitivity—Methotrexate—muscle cancer	0.000104	0.0011	CcSEcCtD
Ketoprofen—Asthenia—Methotrexate—muscle cancer	0.000102	0.00107	CcSEcCtD
Ketoprofen—Feeling abnormal—Doxorubicin—muscle cancer	0.000101	0.00106	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Doxorubicin—muscle cancer	0.0001	0.00106	CcSEcCtD
Ketoprofen—Pruritus—Methotrexate—muscle cancer	0.0001	0.00105	CcSEcCtD
Ketoprofen—Urticaria—Doxorubicin—muscle cancer	9.75e-05	0.00103	CcSEcCtD
Ketoprofen—Abdominal pain—Doxorubicin—muscle cancer	9.71e-05	0.00102	CcSEcCtD
Ketoprofen—Diarrhoea—Methotrexate—muscle cancer	9.7e-05	0.00102	CcSEcCtD
Ketoprofen—PTGS1—Overview of nanoparticle effects—PTGS2—muscle cancer	9.62e-05	0.0133	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	9.44e-05	0.013	CbGpPWpGaD
Ketoprofen—Dizziness—Methotrexate—muscle cancer	9.38e-05	0.000986	CcSEcCtD
Ketoprofen—CXCL8—Bladder Cancer—VEGFA—muscle cancer	9.29e-05	0.0128	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Doxorubicin—muscle cancer	9.05e-05	0.000951	CcSEcCtD
Ketoprofen—Vomiting—Methotrexate—muscle cancer	9.02e-05	0.000948	CcSEcCtD
Ketoprofen—Rash—Methotrexate—muscle cancer	8.94e-05	0.00094	CcSEcCtD
Ketoprofen—Dermatitis—Methotrexate—muscle cancer	8.93e-05	0.000939	CcSEcCtD
Ketoprofen—Headache—Methotrexate—muscle cancer	8.88e-05	0.000934	CcSEcCtD
Ketoprofen—Asthenia—Doxorubicin—muscle cancer	8.81e-05	0.000926	CcSEcCtD
Ketoprofen—Pruritus—Doxorubicin—muscle cancer	8.69e-05	0.000913	CcSEcCtD
Ketoprofen—CXCR1—GPCR ligand binding—PTCH1—muscle cancer	8.51e-05	0.0118	CbGpPWpGaD
Ketoprofen—Nausea—Methotrexate—muscle cancer	8.42e-05	0.000885	CcSEcCtD
Ketoprofen—Diarrhoea—Doxorubicin—muscle cancer	8.4e-05	0.000883	CcSEcCtD
Ketoprofen—ABCC4—Platelet degranulation—IGF2—muscle cancer	8.12e-05	0.0112	CbGpPWpGaD
Ketoprofen—Dizziness—Doxorubicin—muscle cancer	8.12e-05	0.000854	CcSEcCtD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—muscle cancer	8.04e-05	0.0111	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—MYOD1—muscle cancer	8.01e-05	0.0111	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—CD34—muscle cancer	8.01e-05	0.0111	CbGpPWpGaD
Ketoprofen—PTGS1—Eicosanoid Synthesis—PTGS2—muscle cancer	7.98e-05	0.011	CbGpPWpGaD
Ketoprofen—Vomiting—Doxorubicin—muscle cancer	7.81e-05	0.000821	CcSEcCtD
Ketoprofen—Rash—Doxorubicin—muscle cancer	7.74e-05	0.000814	CcSEcCtD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	7.74e-05	0.0107	CbGpPWpGaD
Ketoprofen—Dermatitis—Doxorubicin—muscle cancer	7.73e-05	0.000813	CcSEcCtD
Ketoprofen—Headache—Doxorubicin—muscle cancer	7.69e-05	0.000809	CcSEcCtD
Ketoprofen—CXCL8—Cellular Senescence—HMGA1—muscle cancer	7.34e-05	0.0101	CbGpPWpGaD
Ketoprofen—Nausea—Doxorubicin—muscle cancer	7.29e-05	0.000767	CcSEcCtD
Ketoprofen—CXCR1—GPCR ligand binding—CNR1—muscle cancer	7.19e-05	0.00993	CbGpPWpGaD
Ketoprofen—CXCL8—Bladder Cancer—TP53—muscle cancer	7.02e-05	0.0097	CbGpPWpGaD
Ketoprofen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	6.9e-05	0.00954	CbGpPWpGaD
Ketoprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—muscle cancer	6.68e-05	0.00923	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—CDKN2A—muscle cancer	6.57e-05	0.00908	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KIDINS220—muscle cancer	6.56e-05	0.00906	CbGpPWpGaD
Ketoprofen—SLC22A7—Fluoropyrimidine Activity—TP53—muscle cancer	6.49e-05	0.00896	CbGpPWpGaD
Ketoprofen—PTGS2—S1P1 pathway—VEGFA—muscle cancer	6.02e-05	0.00832	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	5.9e-05	0.00816	CbGpPWpGaD
Ketoprofen—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	5.76e-05	0.00796	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	5.62e-05	0.00776	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—HMGA1—muscle cancer	5.54e-05	0.00766	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—CNR1—muscle cancer	5.36e-05	0.0074	CbGpPWpGaD
Ketoprofen—ABCC4—Fluoropyrimidine Activity—TP53—muscle cancer	5.23e-05	0.00722	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—CDKN2A—muscle cancer	4.75e-05	0.00657	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—muscle cancer	4.75e-05	0.00657	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—MDM2—muscle cancer	4.61e-05	0.00637	CbGpPWpGaD
Ketoprofen—PTGS1—Arachidonic acid metabolism—PTGS2—muscle cancer	4.44e-05	0.00613	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—VEGFA—muscle cancer	4.39e-05	0.00607	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—PTCH1—muscle cancer	4.37e-05	0.00604	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	4.26e-05	0.00589	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—CNR1—muscle cancer	4.06e-05	0.00561	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—PTGS2—muscle cancer	4.05e-05	0.00559	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	3.86e-05	0.00533	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—PTCH1—muscle cancer	3.84e-05	0.00531	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—ANGPT2—muscle cancer	3.82e-05	0.00528	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—CNR1—muscle cancer	3.69e-05	0.0051	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—IGF2—muscle cancer	3.68e-05	0.00508	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—TP53—muscle cancer	3.66e-05	0.00505	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—IGF2—muscle cancer	3.6e-05	0.00498	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	3.5e-05	0.00484	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet degranulation—VEGFA—muscle cancer	3.41e-05	0.00471	CbGpPWpGaD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	3.25e-05	0.00448	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—CNR1—muscle cancer	3.24e-05	0.00448	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—TP53—muscle cancer	3.22e-05	0.00445	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—KIT—muscle cancer	3.06e-05	0.00423	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—CDKN2A—muscle cancer	3.01e-05	0.00416	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	2.97e-05	0.0041	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KIDINS220—muscle cancer	2.96e-05	0.00409	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—MDM2—muscle cancer	2.92e-05	0.00403	CbGpPWpGaD
Ketoprofen—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	2.87e-05	0.00396	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—PTGS2—muscle cancer	2.82e-05	0.0039	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	2.82e-05	0.0039	CbGpPWpGaD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	2.79e-05	0.00385	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TP53—muscle cancer	2.64e-05	0.00365	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.63e-05	0.00363	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PTCH1—muscle cancer	2.58e-05	0.00357	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—VEGFA—muscle cancer	2.55e-05	0.00352	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—CDKN2A—muscle cancer	2.49e-05	0.00344	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TP53—muscle cancer	2.41e-05	0.00333	CbGpPWpGaD
Ketoprofen—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	2.33e-05	0.00322	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—CDKN2A—muscle cancer	2.27e-05	0.00314	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—FOXO4—muscle cancer	2.22e-05	0.00307	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—MDM2—muscle cancer	2.2e-05	0.00305	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CNR1—muscle cancer	2.18e-05	0.00301	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—FH—muscle cancer	2.07e-05	0.00286	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2e-05	0.00276	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PTCH1—muscle cancer	1.97e-05	0.00273	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—IGF2—muscle cancer	1.87e-05	0.00258	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—IGF2—muscle cancer	1.86e-05	0.00257	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—CNR1—muscle cancer	1.83e-05	0.00253	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—PTGS2—muscle cancer	1.81e-05	0.00251	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IGF2—muscle cancer	1.78e-05	0.00246	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—ANGPT2—muscle cancer	1.73e-05	0.00239	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—VEGFA—muscle cancer	1.67e-05	0.00231	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—TP53—muscle cancer	1.67e-05	0.00231	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CNR1—muscle cancer	1.66e-05	0.0023	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—FOXO1—muscle cancer	1.64e-05	0.00227	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—IGF2—muscle cancer	1.63e-05	0.00225	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.59e-05	0.00219	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—FH—muscle cancer	1.57e-05	0.00218	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—VEGFA—muscle cancer	1.54e-05	0.00213	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	1.51e-05	0.00209	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	1.47e-05	0.00203	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TP53—muscle cancer	1.36e-05	0.00188	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.29e-05	0.00178	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.28e-05	0.00177	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—TP53—muscle cancer	1.26e-05	0.00175	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	1.25e-05	0.00173	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—FH—muscle cancer	1.25e-05	0.00173	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KIT—muscle cancer	1.25e-05	0.00173	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—MED12—muscle cancer	1.17e-05	0.00162	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTCH1—muscle cancer	1.16e-05	0.00161	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ENO2—muscle cancer	1.07e-05	0.00147	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TP53—muscle cancer	1.05e-05	0.00146	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.05e-05	0.00145	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—FH—muscle cancer	1.02e-05	0.00141	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—FH—muscle cancer	1.01e-05	0.0014	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FOXO4—muscle cancer	1e-05	0.00138	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MDM2—muscle cancer	9.84e-06	0.00136	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CNR1—muscle cancer	9.83e-06	0.00136	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	9.5e-06	0.00131	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—MED12—muscle cancer	8.89e-06	0.00123	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IGF2—muscle cancer	8.4e-06	0.00116	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	8.34e-06	0.00115	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—FH—muscle cancer	8.28e-06	0.00114	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ENO2—muscle cancer	8.11e-06	0.00112	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IGF2—muscle cancer	8.04e-06	0.00111	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—VEGFA—muscle cancer	7.79e-06	0.00108	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ENO2—muscle cancer	7.69e-06	0.00106	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—VEGFA—muscle cancer	7.47e-06	0.00103	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FOXO1—muscle cancer	7.4e-06	0.00102	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	7.18e-06	0.000992	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—MED12—muscle cancer	7.06e-06	0.000976	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HMGA1—muscle cancer	6.99e-06	0.000966	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	6.84e-06	0.000945	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ENO2—muscle cancer	6.44e-06	0.00089	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.34e-06	0.000876	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FOXO4—muscle cancer	6.27e-06	0.000866	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—muscle cancer	5.88e-06	0.000813	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—MED12—muscle cancer	5.75e-06	0.000794	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—MED12—muscle cancer	5.71e-06	0.00079	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—muscle cancer	5.64e-06	0.00078	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KIT—muscle cancer	5.64e-06	0.000779	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ENO2—muscle cancer	5.24e-06	0.000724	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ENO2—muscle cancer	5.21e-06	0.00072	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—MED12—muscle cancer	4.68e-06	0.000646	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FOXO1—muscle cancer	4.63e-06	0.00064	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MDM2—muscle cancer	4.44e-06	0.000614	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ENO2—muscle cancer	4.26e-06	0.000589	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.1e-06	0.000566	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.07e-06	0.000563	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS2—muscle cancer	3.71e-06	0.000513	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KIT—muscle cancer	3.53e-06	0.000487	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFA—muscle cancer	3.52e-06	0.000487	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFA—muscle cancer	3.37e-06	0.000466	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.33e-06	0.000461	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTGS2—muscle cancer	2.82e-06	0.00039	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MDM2—muscle cancer	2.78e-06	0.000384	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—muscle cancer	2.66e-06	0.000368	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—muscle cancer	2.55e-06	0.000352	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS2—muscle cancer	1.82e-06	0.000252	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS2—muscle cancer	1.81e-06	0.000251	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS2—muscle cancer	1.48e-06	0.000205	CbGpPWpGaD
